| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Aktien im Fokus - SAP: Erholungsrallye möglich - Cantourage, Circus, Evotec, HelloFresh und Renk | 1.445 | 4investors | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| Sa | Sanofi: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study | 641 | GlobeNewswire (Europe) | ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study First head-to-head, double-blind, randomized phase 4 study powered to directly compare the... ► Artikel lesen | |
| Sa | Compass Pathfinder Limited: Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments | 489 | Business Wire | Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical... ► Artikel lesen | |
| Sa | New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings, Neonc Technologies Holdings, Medicus Pharma, YY Group Holding, and Vivos Therapeutics | 391 | ACCESS Newswire | The show also broadcasts as sponsored programming additionally across MENA and Latin America as "Nuevo En La Calle," reaching millions of households worldwide weekly, with expanded digital distribution... ► Artikel lesen | |
| 06:30 | Sanofi's Nuvaxovid Shows Superior Tolerability Over Moderna's MNEXSPIKE In COMPARE Study | 78 | AFX News | PARIS (dpa-AFX) - Sanofi's (SNY, SNYNF,SAN.PA) protein-based COVID-19 vaccine, Nuvaxovid (NVX-CoV2705), demonstrated a significantly better tolerability profile compared to Moderna's latest... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| PERRIGO | 10,020 | 0,98 | +9,78 % | 0,29 | 02.03.2026 | |
| SANOFI | 81,90 | 3,92 | +4,79 % | 4,12 | 05.05.2026 | |
| NOVO NORDISK | 34,440 | 1,57 | +4,56 % | 7,95 | 27.03.2026 | |
| SINOPHARM | 2,239 | 0,08 | +3,57 % | 0,79 | 23.06.2026 | |
| CHUGAI PHARMACEUTICAL | 45,390 | 1,45 | +3,19 % | 66,00 | 29.06.2026 | |
| NOVARTIS | 129,50 | 4,11 | +3,17 % | 3,70 | 10.03.2026 | |
| GSK | 24,610 | 0,76 | +3,09 % | 0,18 | 19.02.2026 | |
| CSPC PHARMA | 0,973 | 0,03 | +3,08 % | 0,15 | 24.06.2026 | |
| ROCHE HOLDING | 359,80 | 10,85 | +3,02 % | 9,80 | 12.03.2026 | |
| KYOWA KIRIN | 13,100 | 0,33 | +2,52 % | 35,00 | 29.06.2026 |